Search Results - "Whitham, R"

Refine Results
  1. 1

    Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial by Lovera, JF, Frohman, E., Brown, TR, Bandari, D., Nguyen, L., Yadav, V., Stuve, O., Karman, J., Bogardus, K., Heimburger, G., Cua, L., Remingon, G., Fowler, J., Monahan, T., Kilcup, S., Courtney, Y., McAleenan, J., Butler, K., Wild, K., Whitham, R., Bourdette, D.

    Published in Multiple sclerosis (01-06-2010)
    “…Background: Memantine, an NMDA antagonist, is effective for moderate to severe Alzheimer’s disease. Objective: Determine whether memantine improves cognitive…”
    Get full text
    Journal Article
  2. 2

    American ginseng does not improve fatigue in multiple sclerosis: a single center randomized double-blind placebo-controlled crossover pilot study by Kim, E, Cameron, M, Lovera, J, Schaben, L, Bourdette, D, Whitham, R

    Published in Multiple sclerosis (01-12-2011)
    “…This study examined the safety and efficacy of an escalating dose (100 mg, 200 mg, 400 mg/day) of American ginseng over 6 weeks in a single-center, randomized,…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis: a randomized, placebo-controlled trial by Lovera, J., Bagert, B., Smoot, K., Morris, C.D., Frank, R., Bogardus, K., Wild, K., Oken, B., Whitham, R., Bourdette, D.

    Published in Multiple sclerosis (01-04-2007)
    “…Objectives To determine if Ginkgo biloba (GB) improves the cognitive performance of subjects with multiple sclerosis (MS). Methods Randomized, double-blind,…”
    Get full text
    Journal Article
  5. 5

    Enhanced recovery programmes for lower limb arthroplasty in the UK by Nagra, N S, Hamilton, T W, Strickland, L, Murray, D W, Pandit, H

    “…Enhanced recovery programmes (ERPs) reduce patient morbidity and mortality, and provide significant cost savings by reducing length of stay. Currently, no…”
    Get full text
    Journal Article
  6. 6
  7. 7

    A highly immunogenic trivalent T cell receptor peptide vaccine for multiple sclerosis by Bourdette, D N, Edmonds, E, Smith, C, Bowen, J D, Guttmann, C RG, Nagy, Z P, Simon, J, Whitham, R, Lovera, J, Yadav, V, Mass, M, Spencer, L, Culbertson, N, Bartholomew, R M, Theofan, G, Milano, J, Offner, H, Vandenbark, A A

    Published in Multiple sclerosis (01-10-2005)
    “…Background: T cell receptor (TCR) peptide vaccination is a novel approach to treating multiple sclerosis (MS). The low immunogenicity of previous vaccines has…”
    Get full text
    Journal Article
  8. 8

    Blocking OX-40/OX-40 Ligand Interaction In Vitro and In Vivo Leads to Decreased T Cell Function and Amelioration of Experimental Allergic Encephalomyelitis by Weinberg, Andrew D, Wegmann3, Keith W, Funatake, Castle, Whitham, Ruth H

    Published in The Journal of immunology (1950) (01-02-1999)
    “…The OX-40R is a member of the TNF receptor family and is expressed primarily on activated CD4+ T cells. When the OX-40R is engaged by the OX-40 ligand…”
    Get full text
    Journal Article
  9. 9

    Expression of a functional antibody fragment in the gut of Rhodnius prolixus via transgenic bacterial symbiont Rhodococcus rhodnii by Durvasula, R.V, Gumbs, A, Panackal, A, Kruglov, O, Taneja, J, Kang, A.S, Cordon-Rosales, C, Richards, F.F, Whitham, R.G, Beard, C.B

    Published in Medical and veterinary entomology (01-05-1999)
    “…Expression within insects of foreign antiparasitic gene products via microbial symbionts could be used to prevent transmission of vector-borne pathogens to…”
    Get full text
    Journal Article
  10. 10

    Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis by WHITHAM, R. H, BOURDETTE, D. N, HASHIM, G. A, HERNDON, R. M, ILG, R. C, VANDENBARK, A. A, OFFNER, H

    Published in The Journal of immunology (1950) (1991)
    “…Relapsing experimental autoimmune encephalomyelitis (R-EAE) can be induced in SJL/J mice by immunization with spinal cord homogenate and adjuvant. The specific…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Location of a new encephalitogenic epitope (residues 43 to 64) in proteolipid protein that induces relapsing experimental autoimmune encephalomyelitis in PL/J and (SJL x PL)F1 mice by Whitham, RH, Jones, RE, Hashim, GA, Hoy, CM, Wang, RY, Vandenbark, AA, Offner, H

    Published in The Journal of immunology (1950) (01-12-1991)
    “…Synthetic peptides of proteolipid protein (PLP) were screened for their ability to induce experimental autoimmune encephalomyelitis (EAE) in SJL/J, PL/J, and…”
    Get full text
    Journal Article
  14. 14

    Interferon beta-1b in secondary progressive MS: Results from a 3-year controlled study by Panitch, Hillel, Miller, Aaron, Paty, Donald, Weinshenker, Brian

    Published in Neurology (23-11-2004)
    “…To evaluate the efficacy and safety of interferon beta-1b (IFNbeta-1b) in subjects with secondary progressive multiple sclerosis (SPMS). This 3-year,…”
    Get full text
    Journal Article
  15. 15

    Treatment of relapsing experimental autoimmune encephalomyelitis with T cell receptor peptides by Whitham, R H, Kotzin, B L, Buenafe, A C, Weinberg, A D, Jones, R E, Hashim, G A, Hoy, C M, Vandenbark, A A, Offner, H

    Published in Journal of neuroscience research (01-06-1993)
    “…Restricted T cell receptor (TCR) VB gene usage by T cells for recognition of antigens involved in the production of experimental autoimmune encephalomyelitis…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Induction of experimental autoimmune encephalomyelitis in severe combined immunodeficient mice reconstituted with allogeneic or xenogeneic hematopoietic cells by Jones, RE, Bourdette, DN, Whitham, RH, Offner, H, Vandenbark, AA

    Published in The Journal of immunology (1950) (15-05-1993)
    “…Severe combined immunodeficient (SCID) C.B-17-scid/scid (H-2d) strain mice are deficient for T and B lymphocytes and lack all of the immune functions…”
    Get full text
    Journal Article
  18. 18

    Response of human T lymphocyte lines to myelin basic protein: association of dominant epitopes with HLA class II restriction molecules by Chou, Y K, Vainiene, M, Whitham, R, Bourdette, D, Chou, C H, Hashim, G, Offner, H, Vandenbark, A A

    Published in Journal of neuroscience research (01-06-1989)
    “…In animals, the selection in vitro of T cell lines to myelin basic protein (MBP) can define immunodominant and encephalitogenic epitopes which are…”
    Get more information
    Journal Article
  19. 19

    MHC-restriction, cytokine profile, and immunoregulatory effects of human T cells specific for TCR Vβ CDR2 peptides: Comparison with myelin basic protein-specific T cells by Chou, Y.K., Weinberg, A.D., Buenafe, A., Bourdette, D.N., Whitham, R., Kaleeba, J.A.R., Robey, I.F., Kavanagh, D.G., Offner, H., Vandenbark, A.A.

    Published in Journal of neuroscience research (15-09-1996)
    “…HLA‐DR2+ patients with multiple sclerosis (MS) that respond to vaccination with TCR Vβ5.2‐38‐58 peptides have increased frequencies of TCR peptide‐specific T…”
    Get full text
    Journal Article
  20. 20

    Specificity of human T cell clones reactive to immunodominant epitopes of myelin basic protein by Chou, Y K, Henderikx, P, Vainiene, M, Whitham, R, Bourdette, D, Chou, C H, Hashim, G, Offner, H, Vandenbark, A A

    Published in Journal of neuroscience research (01-02-1991)
    “…Several recently discovered lines of evidence support the involvement of myelin basic protein (BP)-specific T cells in multiple sclerosis (MS). To identify…”
    Get more information
    Journal Article